癌症病原和阶段向通过凝结物脆弱性
Menghua Wang1, Takudzwa Chiwoneso2, Zimeng Luo2
1State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China; Department of Chemistry, The University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
Trends in pharmacological sciences
|March 7, 2026
概括
核液-液相分离 (LLPS) 组织细胞功能. 异常的LLPS在癌症中产生脆弱的冷凝物,通过利用它们的不稳定性来提供新的治疗点.
科学领域:
- 分子生物学分子生物学
- 生物物理学的生物物理.
- 癌症研究 癌症研究
背景情况:
- 核液-液相分离 (LLPS) 将转录和DNA修复组织成动态凝聚物,这对基因组完整性至关重要.
- 失调的LLPS是瘤发生的关键驱动因素,但其在促进转录成和基因组不稳定性方面的作用尚未完全理解.
研究的目的:
- 审查异常核LLPS在癌症病原和治疗耐药性中的作用.
- 通过凝结物脆弱性提出阶段向作为精密瘤学策略.
主要方法:
- 对LLPS近期生物物理和分子进步的回顾.
- 分析癌症相关突变如何影响凝结物的特性.
- 瘤机制与生物物理漏洞的整合.
主要成果:
- 与癌症相关的突变将LLPS重新连接,形成超稳定但脆弱的凝聚物.
- 异常的核LLPS有助于癌症的转录成和基因组不稳定性.
结论:
- 针对异常核凝聚物的脆弱性提出了一个新的精确瘤学策略.
- 这种方法将瘤机制与癌症治疗的可操作的生物物理漏洞结合起来.
相关概念视频
Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Cancers Originate from Somatic Mutations in a Single Cell
15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K


